InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

- Current share price for DXB : $0.210

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$126 Appendix 3B and Cleansing Statement 10 Nov 2017 5:39PM $0.210 $0.210 fallen by 0%
$126 Updated Equity Research Report Published 8 Nov 2017 4:51PM $0.205 $0.210 risen by 2.44%
$126 Corporate Presentation BioEurope 8 Nov 2017 8:19AM $0.220 $0.210 fallen by 4.55%
$126 Baker Young Stockbroking Issues Flash Note Report 6 Nov 2017 10:42AM $0.220 $0.210 fallen by 4.55%
$126 DMX-200 Phase 2a Data Presentation 2 Nov 2017 9:45AM $0.185 $0.210 risen by 13.51%
$126 Dimerix Phase 2a Subgroup Analysis Results 2 Nov 2017 9:36AM $0.185 $0.210 risen by 13.51%
$126 Quarterly Review and Appendix 4C 31 Oct 2017 12:20PM $0.180 $0.210 risen by 16.67%
$126 Securities on Issue Post Consolidation 31 Oct 2017 8:17AM $0.200 $0.210 risen by 5%
$126 Baker Young Stockbroking initiates coverage on Dimerix 24 Oct 2017 12:31PM $0.010 $0.210 risen by 2,000%
$126 Ethics Committee Approval for Pharmacokinetic Trial 24 Oct 2017 8:23AM $0.010 $0.210 risen by 2,000%
$126 Update - Consolidation/Split - DXB 19 Oct 2017 3:01PM $0.010 $0.210 risen by 2,000%
$126 Results of Meeting 19 Oct 2017 1:57PM $0.010 $0.210 risen by 2,000%
$126 AGM Presentation 19 Oct 2017 8:30AM $0.009 $0.210 risen by 2,233.33%
$126 Dimerix Appoints Medical Advisory Board 18 Oct 2017 8:21AM $0.008 $0.210 risen by 2,525%
$126 Dimerix Receives $545k R&D Tax Refund 17 Oct 2017 1:39PM $0.008 $0.210 risen by 2,525%
$126 Shareholder Update 27 Sep 2017 9:51AM $0.008 $0.210 risen by 2,525%
$126 Notice of Annual General Meeting - corrected 13 Sep 2017 12:12PM $0.010 $0.210 risen by 2,000%
$126 Consolidation/Split - DXB 13 Sep 2017 8:23AM $0.009 $0.210 risen by 2,233.33%
$126 Investor Presentation 13 Sep 2017 8:22AM $0.009 $0.210 risen by 2,233.33%
$126 Notice of Annual General Meeting/Proxy Form 13 Sep 2017 8:21AM $0.009 $0.210 risen by 2,233.33%
$126 DMX-200 tablet manufacture and human study timeline 5 Sep 2017 8:31AM $0.010 $0.210 risen by 2,000%
$126 Appendix 4G and Corporate Governance Statement 30 Aug 2017 2:35PM $0.010 $0.210 risen by 2,000%
$126 Annual Report to shareholders 30 Aug 2017 2:34PM $0.010 $0.210 risen by 2,000%
$126 Preliminary Final Report 30 Aug 2017 2:28PM $0.010 $0.210 risen by 2,000%
$126 Appendix 3B 16 Aug 2017 5:31PM $0.011 $0.210 risen by 1,809.09%

626 - 650 of 745 results

Page 26 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.